A Deacetylase-Deficient SIRT1 Variant Opposes Full-Length SIRT1 in Regulating Tumor Suppressor p53 and Governs Expression of Cancer-Related Genes

REFERENCES

• Ahmed SU, Milner J. 2009. Basal cancer cell survival involves JNK2 suppression of a novel JNK1/c-Jun/Bcl-3 apoptotic network. PLoS One 4:e7305.
   PubMed Web of Science ®Google Scholar
• Allison SL, Stadler K, Mandl CW, Kunz C, Heinz FX. 1995. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 69:5816–5820.
   PubMed Web of Science ®Google Scholar
• Asher G, et al. 2008. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134:317–328.
   PubMed Web of Science ®Google Scholar
• Banks AS, et al. 2008. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 8:333–341.
   PubMed Web of Science ®Google Scholar
• Baxter EW, Cummings WJ, Fournier RE. 2005. Formation of a large, complex domain of histone hyperacetylation at human 14q32.1 requires the serpin locus control region. Nucleic Acids Res. 33:3313–3322.
   PubMedGoogle Scholar
• Bouras T, et al. 2005. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J. Biol. Chem. 280:10264–10276.
   PubMed Web of Science ®Google Scholar
• Bourdon JC, et al. 1997. Further characterisation of the p53 responsive element: identification of new candidate genes for trans-activation by p53. Oncogene 14:85–94.
   PubMedGoogle Scholar
• Bradbury CA, et al. 2005. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 19:1751–1759.
   PubMed Web of Science ®Google Scholar
• Brooks CL, Gu W. 2009. How does SIRT1 affect metabolism, senescence and cancer? Nat. Rev. Cancer 9:123–128.
   PubMed Web of Science ®Google Scholar
• Buckbinder L, et al. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646–649.
   PubMed Web of Science ®Google Scholar
• Chen D, et al. 2008. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 22:1753–1757.
   PubMed Web of Science ®Google Scholar
• Chen J, Marechal V, Levine AJ. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107–4114.
   PubMed Web of Science ®Google Scholar
• Cheng HL, et al. 2003. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 100:10794–10799.
   PubMed Web of Science ®Google Scholar
• Coussens M, Maresh JG, Yanagimachi R, Maeda G, Allsopp R. 2008. Sirt1 deficiency attenuates spermatogenesis and germ cell function. PLoS One 3:e1571.
   PubMedGoogle Scholar
• Das C, Lucia MS, Hansen KC, Tyler JK. 2009. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459:113–117.
   PubMed Web of Science ®Google Scholar
• David CJ, Manley JL. 2010. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24:2343–2364.
   PubMed Web of Science ®Google Scholar
• Donmez G, Wang D, Cohen DE, Guarente L. 2010. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142:320–332.
   PubMed Web of Science ®Google Scholar
• Firestein R, et al. 2008. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 3:e2020.
   PubMed Web of Science ®Google Scholar
• Ford J, Ahmed S, Allison S, Jiang M, Milner J. 2008. JNK2-dependent regulation of SIRT1 protein stability. Cell Cycle 7:3091–3097.
   PubMed Web of Science ®Google Scholar
• Ford J, Jiang M, Milner J. 2005. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res. 65:10457–10463.
   PubMed Web of Science ®Google Scholar
• Fortin A, et al. 2001. APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J. Cell Biol. 155:207–216.
   PubMed Web of Science ®Google Scholar
• Ghosh HS. 2008. The anti-aging, metabolism potential of SIRT1. Curr. Opin. Invest. Drugs 9:1095–1102.
   PubMedGoogle Scholar
• Haigis MC, Guarente LP. 2006. Mammalian sirtuins: emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20:2913–2921.
   PubMed Web of Science ®Google Scholar
• Haupt Y, Maya R, Kazaz A, Oren M. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296–299.
   PubMed Web of Science ®Google Scholar
• Hida Y, Kubo Y, Murao K, Arase S. 2007. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch. Dermatol. Res. 299:103–106.
   PubMed Web of Science ®Google Scholar
• Huffman DM, et al. 2007. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 67:6612–6618.
   PubMed Web of Science ®Google Scholar
• Knight JR, Milner J. 2012. SIRT1, metabolism and cancer. Curr. Opin. Oncol. 24:68–75.
   PubMed Web of Science ®Google Scholar
• Kubbutat MH, Jones SN, Vousden KH. 1997. Regulation of p53 stability by Mdm2. Nature 387:299–303.
   PubMed Web of Science ®Google Scholar
• Kunz C, Pebler S, Otte J, von der Ahe D. 1995. Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res. 23:3710–3717.
   PubMed Web of Science ®Google Scholar
• Lavu S, Boss O, Elliott PJ, Lambert PD. 2008. Sirtuins: novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discov. 7:841–853.
   PubMed Web of Science ®Google Scholar
• Luo J, et al. 2001. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107:137–148.
   PubMed Web of Science ®Google Scholar
• Lynch CJ, Milner J. 2006. Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency. Oncogene 25:3463–3470.
   PubMed Web of Science ®Google Scholar
• Lynch CJ, et al. 2010. SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53. PLoS One 5:e13502.
   PubMedGoogle Scholar
• McBurney MW, et al. 2003. The mammalian SIR2α protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 23:38–54.
   PubMed Web of Science ®Google Scholar
• Meiller A, et al. 2007. p53-dependent stimulation of redox-related genes in the lymphoid organs of gamma-irradiated: mice identification of haeme-oxygenase 1 as a direct p53 target gene. Nucleic Acids Res. 35:6924–6934.
   PubMed Web of Science ®Google Scholar
• Milne JC, et al. 2007. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450:712–716.
   PubMed Web of Science ®Google Scholar
• Motta MC, et al. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551–563.
   PubMed Web of Science ®Google Scholar
• Oliner JD, et al. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857–860.
   PubMed Web of Science ®Google Scholar
• Peritz T, et al. 2006. Immunoprecipitation of mRNA-protein complexes. Nat. Protoc. 1:577–580.
   PubMed Web of Science ®Google Scholar
• Radisky ES, Radisky DC. 2010. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J. Mammary Gland Biol. Neoplasia 15:201–212.
   PubMed Web of Science ®Google Scholar
• Ramsey KM, et al. 2009. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324:651–654.
   PubMed Web of Science ®Google Scholar
• Rodgers JT, et al. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434:113–118.
   PubMed Web of Science ®Google Scholar
• Rogina B, Helfand SL. 2004. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U. S. A. 101:15998–16003.
   PubMed Web of Science ®Google Scholar
• Rubbi CP, Milner J. 2003. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 22:6068–6077.
   PubMed Web of Science ®Google Scholar
• Shieh SY, Ikeda M, Taya Y, Prives C. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325–334.
   PubMed Web of Science ®Google Scholar
• Siliciano JD, et al. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11:3471–3481.
   PubMed Web of Science ®Google Scholar
• Sinclair DA, Guarente L. 1997. Extrachromosomal rDNA circles: a cause of aging in yeast. Cell 91:1033–1042.
   PubMed Web of Science ®Google Scholar
• Stunkel W, et al. 2007. Function of the SIRT1 protein deacetylase in cancer. Biotechnol. J. 2:1360–1368.
   PubMedGoogle Scholar
• Sun Y, Wenger L, Rutter JL, Brinckerhoff CE, Cheung HS. 1999. p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression. J. Biol. Chem. 274:11535–11540.
   PubMed Web of Science ®Google Scholar
• Tippmann F, Hundt J, Schneider A, Endres K, Fahrenholz F. 2009. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J. 23:1643–1654.
   PubMed Web of Science ®Google Scholar
• Tissenbaum HA, Guarente L. 2001. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410:227–230.
   PubMed Web of Science ®Google Scholar
• van der Horst A, et al. 2004. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J. Biol. Chem. 279:28873–28879.
   PubMed Web of Science ®Google Scholar
• Vaziri H, et al. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149–159.
   PubMed Web of Science ®Google Scholar
• Wang RH, et al. 2008. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14:312–323.
   PubMed Web of Science ®Google Scholar